rinsed away. It may form on teeth, mucosa or other solid surfaces. These deposits can be readily visualised with vegetable or synthetic dyes in disclosing solutions, and can become calcified to form calculus.
The dental biofilm is an organised bacterial community which forms when a solid structure is placed in an aqueous environment. In the oral cavity, the solid surfaces are either teeth or restorative materials -the metal, ceramics or acrylic in appliances. Dental biofilms differ from biofilms on mucosal surfaces as they form on nonshedding surfaces; stable com munities can therefore become established.
In the initial stages of biofilm for mation, adsorption of macromolecules (salivary mucins and proteins) results in the formation of an acquired pel licle. Bacteria can readily adhere to these surfaces through adhesins (spe cific surface receptors). Once attached, the bacteria actively grow and syn thesise outer membrane components, which facilitate bacterial adherence. The bacterial mass increases in size due to continued growth of those mi crobes already adhering to the biofilm, and by the adherence of new microbes. The synthesis of extracellular polymers further facilitates adherence of bac terial species that are unable to adhere directly to pellicle.
The superficial layer is loose and irregular in appearance and is itself bordered by a fluid layer. As the thick ness of the biofilm increases, diffusion of nutrients in and out becomes pro gressively more difficult. Oxygen gradients form as a result of rapid utili sation by superficial bacterial layers and poor diffusion of oxygen through the biofilm matrix. Anaerobic condi tions eventually develop. Supragingival plaque obtains
BIOFILMS
Dental plaque is a bacterial biofilm which causes chronic gingivitis and periodontitis. Conceptually, one may regard periodontal disease as a host-microbial interaction in which both host and bacterial factors determine the outcome, such that changes in the balance between host and bacterial factors can result in a change from health to disease. The balance may be changed, for example, by a reduc tion in the host resistance, an increase in the plaque biofilm or an increase in bacterial virulence. The clinical manifestation of periodontal disease is further modified by local and/or systemic factors.
Development of the plaque biofilm
The plaque biofilm may be defined clinically as bacterial deposits which cannot be easily An appreciation of dental plaque and the host response provides an essential basis from which to understand the disease process and treatment rationale. This information will help the reader to understand not only the way that plaque may have an impact on oral tissues but also why regular effective cleaning may improve periodontal health and why some individuals appear to have a greater susceptibility to periodontitis than others, either intrinsically or in relation to various systemic factors.
nutrients from dietary products dissolved in saliva, whereas microbes in the depths of the periodontal pockets obtain nutrients from the periodontal tissues, gingival crevicular fluid, blood supply or other mi croorganisms.
The primary colonisation consists of aerobic and facultative anaerobes such as Gram-positive cocci (e.g. streptococci). Gram-positive rods appear, increase in number and eventually outnumber the cocci. Gram-positive filaments, such as Actinomyces spp., may later predominate. There are specific surface receptors on the Gram-positive cocci and rods that allow the adherence of Gram-negative bacteria, which otherwise lack the ability to attach directly to pellicle. As time progresses there is a shift in the microflora from Gram-positive to Gram-negative organisms, and an increase in heterogeneity of the mi crobial species.
Stable bacterial communities are established with nutrients being ex changed between different microbes and also the production of bacteriocins (which kill specific bacteria). The local environment may protect growing plaques, for example in stagnation areas where the microbes are effectively housed away from the self-cleansing actions within the oral cavity. Specific bacterial communities are then established in different sites, according to the local environments, with differences existing between the shallow gingival crevice compared with a deep periodontal pocket, a flat enamel surface compared with a fis sure. These communities are more re sistant to antibiotics and effectively require much higher doses to exert a microbicidal effect as a result of the complex inter-relationships within these bacterial communities. • Summarises the development of the plaque biofilm.
• Highlights that periodontal disease is largely driven by the presence of plaque.
• Discusses the role of bacteria in the aetiology of periodontal disease.
• Suggests future treatment strategies for periodontal disease by improving the host's ability to prevent colonisation or by eliminating the microbial species. 
CLINICAL GUIDE TO PERIODONTOLOGY* ROLE OF BACTERIA IN PERIODONTAL DISEASE
Although there is evidence that bacterial plaque/biofilms play a major role in the aetiology of periodontal disease, it is not clear whether the bacteria initiate disease non-specifically or specifically (Fig. 1) . There are now three hypotheses about the role of bacteria in periodontal disease, which largely ignore, however, the role of host factors (see the 'Host responses' section below).
Non-specific plaque hypothesis
Periodontal disease is due to bacterial accumulation, irrespective of its composition.
This implies that no one specific bacterial species is any more significant than another in its ability to cause periodontal disease. The implication from the non-specific plaque hypothesis is that all patients must maintain a high standard of oral hygiene to prevent periodontal disease, as all bacteria are perceived as playing a role. Although the amount of plaque present may correlate well with disease severity in cross-sectional studies, it correlates poorly in longitudinal studies. This hypothesis does not consider variations in the dental biofilm that may affect its pathogenicity or, most importantly, host determinants.
Specific plaque hypothesis

Periodontal disease is the result of an infection with a single specific pathogen.
This may help to explain why there are many patients who have consid erable plaque deposits but only a minority suffer from severe destructive periodontitis. The implications from the specific pathogen hypothesis are that one need only worry about the bacterial pathogen responsible for pe riodontal disease, and therefore need only employ procedures that lead to the elimination of this species and not all other bacterial species. Treatment could specifically target the iden tified pathogen as one would do for any other monospecific infection such as tuberculosis or syphilis.
If one assumes that the 'real' pathogen is a strict anaerobe, it may be unnecessary to eliminate all plaque deposits and sufficient to either elim inate the pathogen or promote the development of a new community where anaerobes are unable to survive. This may be achieved by simply disrupting the biofilm and could explain the success that is achieved by root surface debridement. Special-risk patients might be identified by the pres ence of the specific pathogen in the oral cavity. This might lead to treat ments targeted at specific bacteria, employing antibiotic chemotherapy once the antibiotic sensitivities are known, or newer therapeutic measures including vaccinations, or the use of peptides to prevent bacterial adherence and the ensuing colonisation. However, to date no one pathogen has been specifically linked to chronic gingivitis or periodontitis. The increased relative risk of aggressive pe riodontitis in adolescent Moroccans who have Aggregatibacter actinomycetemcomitans, particularly the JP2 clone, is the most compelling ev idence for a role of a single species in periodontal disease.
Multiple pathogen hypothesis
Periodontal disease is the result of in fection with a relatively small number of interacting bacterial species.
One major difficulty lies in identifying the possible combinations of pathogens that are important. It should be appreciated that this current list of periodontopathogens may be superseded once the results from bacterial culture and isolation using molecular techniques are combined and reinterpreted. One could, nevertheless, arbitrarily determine antibiotic sen sitivities of the top ten periodon topathogens and then employ these antibiotics to eliminate the organisms.
Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia, Treponema denticola, Fusobacterium nucleatum and Campylobacter spp. are present in diseased sites and have been implicated in disease progression. However, this in itself does not prove that they are responsible for tissue damage, and indeed one may argue that these organisms are more likely to be found in deeper pockets and at the sites with more inflammation sim ply because they thrive in such ecological niches.
DIFFICULTIES IN ESTABLISHING THE AETIOLOGY OF PERIODONTAL DISEASE
One may wonder why it is so difficult to identify the cause of such a relatively common disease. There are many problems in trying to determine which organisms are important in the pathogenesis of periodontal disease:
• Over 600 species may be identified from the periodontal pockets of different individuals; there may be between 30 and 100 species for any single site 
HOST RESPONSES
One should remember that both chronic gingivitis and periodontitis are chronic inflammatory lesions and therefore display inflammation as well as attempts at healing. One can detect the cardinal signs of inflammation and various degrees of repair. Not all signs have to be present in order to establish that inflammation is pres ent; for example, pain and loss of function is neither necessarily present nor common in these conditions.
Innate immunity
The host immune response may be conveniently divided into innate and adaptive immunity (Fig. 2) . Both in nate and adaptive immunity operate together and not in isolation, com plementing each other to maintain health and prevent disease.
Innate immune mechanisms include a number of relatively non-specific mechanisms, including the barrier ef fect of an intact epithelium. Oral mucosa is bathed in saliva, which contains a number of protective factors. Bac teria can be recognised by nonclonal receptors, otherwise known as pattern recognition receptors. These receptors recognise substances such as lipo polysaccharide (LPS) from Gram-negative bacteria and peptidoglycan from Gram-positive bacteria. Innate responses are relatively non-specific and there is therefore greater potential for bystander damage to tissues. Neutrophils appear to be crucial for the maintenance of periodontal health, as disease severity is increased in neutropenia, agranulocytosis and where cellular function is impaired, such as leukocyte adhesion deficiency, lazy leukocyte disease and PapillonLefèvre, Chediak-Higashi and Down's syndromes, as well as diabetes mellitus.
Adaptive immunity
The adaptive immune response is characterised by specificity, memory and the capacity to distinguish self from non-self. Once In humoral or cell-mediated immunity, specificity of the responses is thought to limit by stander damage by focusing the adap tive or specific immune system. Secretory IgA (sIgA) protects mu cosal surfaces, mainly by preventing bacterial adherence. If bacteria cannot adhere to this epithelial surface then they are less likely to be able to cause infection. sIgA is different from serum IgA in that it consists of dimers of IgA held together by a joining chain (or J-chain) and protected from pro teolytic breakdown with secretory component.
Gingival crevicular fluid originates from gingival capillaries and contains some immune cells. The fluid flow is continuous into the gingival crevice but increases during gingival inflam mation. Antibodies such as IgG, IgA and IgM, complement components, as well as enzymes are found in it. These soluble proteins and cellular components then enable innate and adaptive responses to occur at the site of bacterial challenge.
HISTOPATHOLOGY OF PERIODONTAL DISEASE
The histopathology of periodontal disease may be divided into initial, early, established and advanced lesions based on studies of experimental gin givitis in humans and periodontitis in animals (Table 1) . Although one should be careful about how this evi dence is interpreted, it nevertheless provides a useful framework from which to construct an understanding of disease pathogenesis.
It is worth noting that an established lesion can persist for many years and the change to an advanced lesion marks the transition from a chronic and successful defence reaction to a destructive immunopathological mech anism (periodontitis). The factors re sponsible for this progression are un known. There are two principal schools of thought: 1. Host immune response may be involved 2. Some specific microorganism in bacterial plaque, or change in virulence, may be responsible for the development of the advanced lesion.
The biggest problem is establishing which factors are responsible for the transition from reversible gingivitis to destructive periodontitis. There is no real evidence to suggest that de structive periodontitis necessarily de velops from pre-existing gingivitis. Some preceding gingival inflammation may lead to periodontitis but this is not always the case.
The 'advanced' lesion is clinically recognised as periodontitis, with the classical features of pocket formation, ulceration of the pocket's epithelium, destruction of the collagenous peri odontal ligament, and bone resorp tion. These changes lead to mobility and eventually to tooth loss. There is an extension of the inflammatory in filtrate apically and laterally, with re duction of the collagen content and a dense accumulation of lymphocytes, plasma cells and macrophages. Pe ripherally there is reparative fibrosis. There is a breakdown of the epithelial barrier between plaque and periodon tal connective tissue, which might be associated with a significant change in the immune response and permit direct access of plaque antigens and metabolites. At this stage there is ir reversible loss of attachment, and loss of periodontal ligament and bone with progressive increase in pocket formation. High concentrations of IgG, IgA, IgM and complement as well as polymorphs can be found in gingival crevicular fluid. However:
• Antibodies are inconsistently invoked in periodontitis and do not appear to protect from disease • Antibody titres may rise during treatment but this is more likely a consequence of instrumentation effectively inoculating antigens • Antibody titres may reflect more the intrinsic mitogenicity or immunogenicity of plaque antigens rather than the importance of any one microbial organism in the pathogenesis of periodontal disease. • Impairment of polymorphonuclear leukocyte (PMN) function (chemotaxis, phagocytosis and intracellular killing).
• Dysregulation of cytokine networks (Porphyromonas gingivalis and R1 proteinase).
• Degradation of immunoglobulins (Capnocytophaga spp).
• Degradation of fibrin, which would otherwise trap bacteria and facilitate phagocytosis.
• Increase in mucosal permeability and disaggregation of proteoglycans by disrupting -SH (sulphydryl) bonds, or impaired host cell function; degradation of collagen by fibroblastic collagenase by volatile sulphur compounds from Gram-negative anaerobes (Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia, Treponema denticola).
• Breakdown of periodontal tissues, by proteolytic enzymes, to peptides and amino acids thereby providing nutrients for Gram-negative bacteria: -Collagenases (Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans and spirochaetes). -Trypsin-like proteinases (Porphyromonas gingivalis, Tannerella forsythia). Other hydrolytic enzymes that destroy non-protein extracellular matrix.
• Activation of complement and bone resorption by endotoxin (LPS).
• Bone resorption stimulated by lipoteichoic acid from Gram-positive bacterial cell walls.
Indirect damage via the host response
• Triggering humoral immunity leads to activation of complement and more inflammation, recruitment of inflammatory cells and then their release of tissue destructive enzymes.
• Polyclonal activation of B cells, thereby preventing useful specific antibody production. Non-specific antibody is produced preventing adaptive immune responses from focusing on those antigens that would lead to protection. LPS is an example of a B-cell mitogen, stimulating polyclonal activation of B cells.
• Cellular immunity-activated T cells activate antigen-presenting cells and macrophages, which then release a number of cytokines: IL-1β, TNF-α and IL-6; autoreactive/cytotoxic responses to periodontal tissue.
• PMNs release enzymes that can destroy tissue (matrix metalloproteinases, including collagenases, elastases, stromelysins).
Table 3 Cytokines in inflammatory conditions
Cytokine Effect
IL-1β
Bone resorption; pro-inflammatory; fever TNF-α Bone resorption; pro-inflammatory; fever; synergistic with IL-1β IL-6 B-cell differentiation; antibody production; osteoclast differentiation
The mechanisms involved in mediating tissue damage are more easily de scribed as hypersensitivity-like re sponses and include antibody-medi ated, cellular cytotoxicity, and IgE mediated hypersensitivity-like reac tions.
MECHANISMS OF TISSUE DESTRUCTION
Bacteria can cause damage directly and indirectly. The various mecha nisms are described in Table 2 . Cyto toxic cellular immune responses to self, and pro-inflammatory responses involving release of interleukin 1β (IL-1β), tumour necrosis factor α (TNF-α) and interleukin6 (IL-6) could lead to tissue destruction (Table 3) .
CONCLUSION AND POTENTIAL FUTURE TREATMENT STRATEGIES
Periodontal disease represents a com plex interaction between host and microbes. In future one could employ strategies which improve the host's ability to prevent bacterial colonisation or eliminate the important microbial species. For example, attention has been focused on eliciting immune re sponses to adhesins and proteases of Porphyromonas gingivalis. Alterna tively, preformed antiadhesin anti-bodies could be produced and applied to dental surfaces to prevent attachment and bacterial colonisation.
If one believes that the presence of plasma cells is linked to the ensuing tissue destruction in periodontitis, then one could tip the balance in favour of diminishing the humoral response by altering the pro-inflam matory/ anti-inflammatory antibody responses, (Th1/ Th2 CD4 T helper cell populations) so that plasma cell differentiation is much reduced or absent.
Suppressing exaggerated host re sponses, restoring balance or regulation of dysregulated cytokine networks, or tipping the Th1-type response to a Th2 response (anti-inflammatory but with a protective humoral response) could lead to prevention of disease progression. Intervention, for example in the form of receptor-mediated an tagonism, could help regulate the complex cytokine networks, thereby lim iting bystander damage at foci of in flammation. However, there are so many potential antigens that could be affecting the outcome it is unlikely that such immunomodulation could be of clinical benefit to patients in the near future.
There is far more heterogeneity in human CD4 T cell populations in terms of their cytokine expression than has previously been thought, making it difficult to identify T cell populations as either Th1 or Th2 subsets. Given this difficulty, the Th1/Th2 paradigm has been developed to include other T cell subsets: Th17 cells and regulatory T cells (T reg ). Th17 cells can produce pro-inflam matory IL-17 and, under the influence of other cytokines such as IL-12, can develop into Th1 cells. There is also developmental plasticity between Treg cells, such that in the appropriate cy tokine milieu (IL-6 and IL-21) they can switch to Th17 cells. This functional plasticity offers potentially dif ferent therapeutic approaches, in which Th17 and/or T reg cells are the im munological targets rather than Th1 or Th2 subsets or the elusive microbial antigens.
Further reading
